Kovack Advisors, Inc. Moderna, Inc. Transaction History

Kovack Advisors, Inc.

$887 Million
Q2 2024

A detailed history of Kovack Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Kovack Advisors, Inc. holds 1,898 shares of MRNA stock, worth $124,793. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,898

Previous 2,731 30.5%

Holding current value

$124,793

Previous $291,000 22.68%

% of portfolio

0.03%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$101.21 - $166.61 $84,307 - $138,786	-833 Reduced 30.5%	1,898 $225,000
Q1 2024 Apr 19, 2024	BUY	$85.37 - $115.44 $1,963 - $2,655	23 Added 0.85%	2,731 $291,000
Q4 2023 Feb 02, 2024	SELL	$69.51 - $104.43 $46,015 - $69,132	-662 Reduced 19.64%	2,708 $269,000
Q3 2023 Oct 19, 2023	SELL	$96.41 - $126.61 $2,603 - $3,418	-27 Reduced 0.79%	3,370 $348,000
Q2 2023 Jul 21, 2023	SELL	$118.5 - $160.53 $180,357 - $244,326	-1,522 Reduced 30.94%	3,397 $412,000
Q1 2023 Apr 20, 2023	BUY	$135.66 - $197.02 $13,837 - $20,096	102 Added 2.12%	4,919 $755,000
Q4 2022 Feb 22, 2023	SELL	$118.38 - $210.04 $76,710 - $136,105	-648 Reduced 11.86%	4,817 $865,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $8,264 - $13,592	70 Added 1.3%	5,465 $646,000
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $82,576 - $124,495	-705 Reduced 11.56%	5,395 $771,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $93,453 - $173,701	-739 Reduced 10.81%	6,100 $1.05 Million
Q4 2021 Jan 18, 2022	SELL	$225.82 - $368.51 $750,174 - $1.22 Million	-3,322 Reduced 32.69%	6,839 $1.74 Million
Q3 2021 Nov 03, 2021	BUY	$221.9 - $484.47 $424,716 - $927,275	1,914 Added 23.21%	10,161 $3.91 Million
Q2 2021 Jul 29, 2021	SELL	$129.91 - $234.98 $14,679 - $26,552	-113 Reduced 1.35%	8,247 $1.94 Million
Q1 2021 May 04, 2021	SELL	$109.18 - $185.98 $20,198 - $34,406	-185 Reduced 2.17%	8,360 $1.1 Million
Q4 2020 Jan 14, 2021	SELL	$65.74 - $169.86 $53,709 - $138,775	-817 Reduced 8.73%	8,545 $893,000
Q3 2020 Nov 02, 2020	BUY	$54.34 - $94.85 $309,248 - $539,791	5,691 Added 155.03%	9,362 $662,000
Q2 2020 Jul 31, 2020	BUY	$29.67 - $80.0 $108,918 - $293,680	3,671 New	3,671 $236,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Account

Kovack Advisors, Inc. Moderna, Inc. Transaction History